WeightWatchers soars after Sequence acquisition
4.8 (86) · € 16.50 · En Stock
WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weight Watchers: Better-Than-Expected Q2, But Long-Term Challenges
With Ozempic popularity on the rise, WW jumps into obesity drugs
WW's stock soars after deal to buy weight-loss drug prescriber
WW International - Recent News & Activity
WeightWatchers Stock Soars After Telehealth Deal Closes
WeightWatchers jumps into into the prescription weight loss drug
WeightWatchers Acquires Sequence, Enters Obesity Drug Market
Cytokinetics Said to Weigh Options Amid Takeover Interest - Bloomberg
WeightWatchers to buy Sequence telehealth, enter obesity drug
WeightWatchers moves into obesity drug market with Sequence
